Enlarged nephrons and severe nondiabetic nephropathy in hepatocyte nuclear factor-1β (HNF-1β) mutation carriers  by Sagen, Jørn V. et al.
Kidney International, Vol. 64 (2003), pp. 793–800
Enlarged nephrons and severe nondiabetic nephropathy in
hepatocyte nuclear factor-1 (HNF-1) mutation carriers
JØRN V. SAGEN, LEIF BOSTAD, PA˚L R. NJØLSTAD, and ODDMUND SØVIK
Department of Pediatrics and Department of Pathology, Center for Genetics and Molecular Medicine, University of Bergen,
Haukeland University Hospital, Bergen, Norway
Enlarged nephrons and severe nondiabetic nephropathy in he-
patocyte nuclear factor-1 (HNF-1) mutation carriers.
Background. Mutations in hepatocyte nuclear factor-1
(HNF-1) lead to a syndrome with diabetes and urogenital
malformations [maturity onset of diabetes of the young, type
5 (MODY5)]. The aim of this study was to perform a clinico-
pathologic investigation of the renal disease in members of a
Norwegian family with the HNF-1 mutation R137-K161del.
Methods. The study was based on long-term clinical observa-
tions of five mutation carriers, combined with renal biopsies
from four of these. The biopsies were examined by light micros-
copy, immunohistochemistry, and transmission electron mi-
croscopy. The diameter of the glomerulus, proximal and distal
tubules, in addition to thickness of the glomerular basement
membrane (GBM), were measured in light microscopic slides
and transmission electron micrographs. The results were com-
pared with biopsies from adult patients with diabetic glomeru-
lopathy, glomerulonephritis, and/or benign nephrosclerosis, and
children with minimal-change glomerulopathy or glomerulo-
nephritis, respectively.
Results. Clinically, there was a wide intrafamilial variation
from stable or slightly increasing serum creatinine to progres-
sive renal failure and end-stage renal disease (ESRD). In all
cases, the kidney disease was diagnosed prior to diabetes. Hy-
pertrophy of the proximal and distal tubules as well as enlarged
glomeruli were found in three of four mutation carriers. Essen-
tially normal nephrons were found in the 10-year-old boy.
The thickness of the GBM was considered near normal in
all mutation carriers. Oligomeganephronia was found in one
patient.
Conclusion. Histopathologic and morphometric studies of
kidney biopsies from four carriers of an HNF-1 mutation
revealed enlarged glomeruli and tubular structures. Long-term
clinical follow-up demonstrated that the renal disease devel-
oped prior to and independently of diabetes. Finally, there is
a wide phenotypic variation of the renal disease caused by
HNF-1 mutations.
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Mutations in hepatocyte nuclear factor-1 (HNF-1)
are associated with a syndrome characterized by diabetes,
severe renal disease, and genital malformations [1–4].
This syndrome (MIM # 604284) referred to as maturity
onset diabetes of the young (MODY) type 5, also known
as the renal cysts and diabetes syndrome, involves kid-
neys, endocrine pancreas, genital system [4–6], hepatic
function [7], and possibly the central nervous system [8].
The nephropathy is the most serious part of the syndrome,
in some cases leading to kidney failure and transplantation.
HNF-1, which is a nuclear protein essential in forma-
tion and differentiation of several organs, appears in the
metanephros during early embryonal development [9–11].
Functional changes of the protein potentially cause de-
velopmental disorders in several organs. However, the
nature of the hereditary nephropathy associated with
HNF-1 mutations is not well understood. A few histo-
pathologic investigations based on renal biopsies have
resulted in diagnoses such as oligomeganephronia [4, 12],
cystic dysplasia [6], and hypoplastic glomerulocystic kid-
ney disease [13, 14]. Absence of normal nephrogenesis
was observed in a 17-week-old fetus [15].
A Norwegian family [4], including five HNF-1 muta-
tion carriers in three consecutive generations gave us an
opportunity to study the renal disease with regard to
long-term clinical follow-up. In order to study the ne-
phropathy in this family in more detail, we obtained
kidney biopsies from four of the mutation carriers for
light and transmission electron microscopy and morpho-
metric analyses.
METHODS
Subjects
The pedigree of the Norwegian family is shown in
Figure 1. Mutation analysis previously demonstrated an
in-frame deletion (R137-K161del) in HNF-1 [4].
The study was based on written informed consent, and
performed according to the Declaration of Helsinki.
Case I-1. In her twenties, subject I-1 had several epi-
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Fig. 1. Pedigree of a Norwegian family with
hepatocyte nuclear factor-1 (HNF-1) (R137-
K161del) mutation. Filled symbols indicate af-
fected subjects, while open symbols demon-
strate healthy individuals. Abbrevations are:
CRF, chronic renal failure; CRI, chronic renal
insufficiency; ESRD, end-stage renal disease;
DM, diabetes mellitus; N, normal allele; M,
mutated allele; MA, Mu¨llerian aplasia.
sodes of pyelonephritis. At age 42 years she was admitted
to hospital with proteinuria and reduced kidney function
(serum creatinine 153 mol/L; normal range 65 to 100
mol/L). Renal ultrasonography revealed a small right
kidney with increased echo density, a normal left kidney,
and no cysts. Intravenous pyelography (IVP) demon-
strated papillary changes consistent with earlier pyelo-
nephritis. Proteinuria was present during every pregnancy,
the first at age 25 years. During her fourth pregnancy
(age 36 years), gestational diabetes was diagnosed, and
impaired glucose tolerance (IGT) sustained after delivery.
She developed manifest diabetes 52 years old. Antihyper-
tensive treatment was initiated at age 51 years. Chronic
renal failure (CRF) was diagnosed when she was 52 years
old with serum creatinine of 228 mol/L. At age 57 years,
serum creatinine was 285 mol/L and elevated micro-
albuminuria was present (0.048 g/L; normal range 0 to
0.020 g/L). Renal ultrasonography demonstrated small
kidneys with loss of renal parenchyma and small cysts
in the right kidney.
Case II-2. Proteinuria was detected at a school health
screening when the female patient was 10 years old. IVP
demonstrated normal renal anatomy. Reduced filling
within the renal pelvices was interpreted as reduced kid-
ney function. Renal ultrasonography at age 13 showed
abnormal echo density and no cysts. Renal biopsy dem-
onstrated reduced number and enlarged nephrons with
hypertrophy of the proximal tubules, consistent with oli-
gomeganephronia. Shortly after a delivery at the age of
22 years, she developed diabetes, initially treated with
insulin, but later with diet. Blood pressure was consis-
tently normal. End-stage renal disease (ESRD) was diag-
nosed when she was 28 years old, and a kidney trans-
plantation was done.
Case II-4. At age 6 months, the female patient had
convulsive seizures. An electroencephalogram (EEG),
x-ray film of the skull, and fasting blood glucose were
normal. Subsequently, she showed failure to thrive and
delayed psychomotor development. Slight metabolic aci-
dosis suggested a renal tubular disorder. IGT was docu-
mented at age 16 months. Intermittent proteinuria was
observed when she was 4 years old. IVP at age 7 years
demonstrated reduced contrast filling within both kid-
neys. Multicystic left kidney was registered at the age of
7 years during an attempted surgical biopsy. Gynecologic
examination and rectal ultrasonography at age 22 years
revealed vaginal aplasia, rudimentary uterus, but normal
ovaries. Serum creatinine increased progressively with
age (Fig. 2), and ESRD was diagnosed when she was
20 years old. Her blood pressure was normal. Renal
transplantation was performed at age 21 years. During
treatment with glucocorticoids, she developed insulin-
requiring diabetes. From 22 years on, she developed a
condition resembling multiple sclerosis. The condition
progressed into skeletal muscle paralysis, blindness, and
motoric aphasia. She died aged 27.
Case II-6. When the female patient was 11 years old,
elevated serum creatinine, reduced urine concentration
capacity, and nocturnal enuresis were observed. Renal
ultrasonography was normal. At age 14 years, she was
diagnosed with insulin-requiring diabetes. Computed to-
mography showed normal renal parenchyma and liver.
At 17 years old, a gynecologic examination revealed
vaginal aplasia and rudimentary uterus. Serum concen-
trations of sex hormones and cortisol were normal. Urine
microalbumin of 0.084 g/L (normal range 0 to 0.020 g/L)
and chronic renal insufficiency (CRI) were observed at
the age of 18 years. Blood pressure was normal.
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Fig. 2. Serum creatinine during an observation time from 9 to 17 years
in five subjects from a Norwegian family with hepatocyte nuclear factor-
1 (HNF-1) mutation. Each value represents the mean of all measure-
ments obtained during 1 year. Symbols: Subject I-1 (); Subject II-2
(); Subject II-4 (); Subject II-6 (); Subject III-3 ().
Case III-3. After a premature delivery, the male pa-
tient presented with neonatal hypoglycaemia and failure
to thrive. Metabolic acidosis, glucosuria, generalized
amino aciduria and slight proteinuria were observed 10
days after delivery. At 3 months old, serum creatinine
was in the upper normal range (67 mol/L; normal range
35 to 80 mol/L). Renal ultrasonography demonstrated
slightly increased echo density of the renal parenchyma
without cysts. Two years later, the amino aciduria was
nearly normalized. When he was 6 years old, an oral
glucose tolerance test was normal. Ultrasonography re-
vealed normal internal genital organs and left kidney,
while the right kidney had increased echo density with a
subcortical cyst. Urine microalbumin was elevated (0.048
g/L; normal range 0.000 to 0.020 g/L). At age 9 years, a
renal ultrasonography revealed four cortical cysts in the
right kidney, while an irregular structure with increased
echo density was observed in the upper pole of the left
kidney. Serum creatinine was 82 mol/L and creatinine
clearence was 61 mL/1.73 m2. Blood pressure was normal.
Materials
In the mutation carriers, renal biopsies were obtained
from four cases in three consecutive generations (cases
I-1, II-2, II-6, and III-3). Percutaneous renal biopsies
were obtained by ultrasound guidance using a 16-gauge
needle. The biopsy specimens were formalin-fixed, paraf-
fin-embedded, and prepared for light microscopy and
immunohistochemistry. Material for transmission elec-
tron microscopy was fixed in a formaldehyde-glutaralde-
hyde mixture and postfixed in osmium tetroxide.
Light and transmission electron microscopy. Hema-
toxylin and eosin (H&E) and periodic-acid Schiff (PAS),
or toluidine blue (case III-3)-stained slides were exam-
ined by light microscopy. Changes in glomeruli, tubulo-
interstitial tissue, and vessels in addition to the diameters
of the Bowman’s space, glomerular tufts, and the tubules
were recorded. The thickness of the glomerular base-
ment membrane (GBM) was measured from the electron
micrographs.
Morphometric measurements. The morphometric mea-
surements done on the biopsies from our cases were
compared with results from three control groups con-
sisting of biopsies obtained from the Norwegian Kidney
Registry at Department of Pathology, Haukeland Uni-
versity Hospital. Control group 1 included biopsies from
13 adult subjects with diabetic nephropathy. Control
group 2 included 11 adult subjects in whom renal biopsy
was done due to glomerulonephritis or benign nephro-
sclerosis. Renal biopsies from 12 children showing mini-
mal-change glomerulopathy or glomerulonephritis con-
stituted control group 3.
All morphometric measurements were performed by
the same investigator (J.V.S.) and controlled by an expe-
rienced nephropathologist (L.B.). From the mean value
of the perpendicular diameter of Bowman’s space and
glomerular tuft, the area was calculated. In the mutation
carriers, the measurements were performed in the num-
ber of glomeruli present in each slide (all slides contained
less than 10 glomeruli), while in the control groups, 10
different glomeruli were selected in each specimen. The
mean values of the perpendicular diameter of the proxi-
mal and distal tubules were obtained. The GBM thick-
ness was measured from the electron micrographs at
6000 or 8800 magnification. The GBM width was
recorded at 20 different randomly selected sites. Results
from six patients of control group 1, five patients in
control group 2, and seven patients in control group 3
were selected for these measurements.
Statistical analysis
Statistical analyses were performed between control
groups 1 and 2. This was done with Mann-Whitney U test
using an SSSP 11.0 package. A P value less than 0.05
was considered statistically significant.
RESULTS
Clinical characteristics
Clinical characteristics of the mutation carriers are
presented in Table 1. Renal disease was diagnosed at
11  7 years (range 3 to 20 years) prior to diabetes in
four cases (I-1, II-2, II-4, and II-6), whereas subject III-3
is still normoglycemic. As shown in Figure 2, renal func-
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Table 1. Clinical characteristics of subjects from a Norwegian family with a hepatocyte nuclear factor-1 (HNF-1) mutation
Renal Diabetes
Present Renal disease Serum Renal mellitus
Gender age biopsy diagnosed creatinine U-albumin cysts diagnosed Hypertension
ID F/M years age in years age in years lmol/La g/Lb / age in years /
I-1 F 58 57 42 285 0.048  52c 
II-2 F 33 13 10 453 0.449  22 
II-4 F 27f NA 1 643 NA  21d 
II-6 F 22 21 11 118 0.084  14 
III-3 M 10 9 3 months 82 0.048  NGTe 
Abbreviations are: F, female; M, male; NA, not available; NGT, normal glucose tolerance; IGT, impaired glucose tolerance.
a Reference values (adult females 65 to 100 mol/L; children 35 to 80 mol/L)
b Normal range 0.000 to 0.020 g/L
c Gestational diabetes at age 35 years, IGT after delivery
d IGT at age 1 year, manifest diabetes 21 years old
e Intermittent glucosuria, borderline oral glucose tolerance
f Age at death
Table 2. Morphometric measures in renal biopsies from four subjects with hepatocyte nuclear factor-1 (HNF-1) mutation compared with
control groups
Glomerular tuft Bowman’s space Proximal tubules Distal tubules GBM
ID l2 l2 diameter, mm diameter, mm thickness, nmc
I-1 25,873, 31,731 (2)a 33,168, 61,136 (2)a 11525 (10)a 7719 (10)a 363100
II-2 83,02912,946 (3) 111,26318,687 (3) 12025 (10) 612 (5) 37996
II-6 40,8626009 (4) 49,3928260 (4) 8417 (10) 6011 (10) 33363
III-3 14,4473210 (4) 15,6793524 (4) 6210 (10) 5313 (5) 34179
Control group 1 (N  13) 26,5239853 (10) 31,55211,113 (10) 6515 (10) 4510 (10) 649194 (6)b
Control group 2 (N  11) 22,1056209 (10) 26,5966867 (10) 6110 (10) 438 (10) 37474 (5)b
Control group 3 (N  12) 17,8255800 (10) 20,7996533 (10) 608 (10) 427 (10) 348106 (7)b
Abbreviations are: GBM, glomerular basement membrane.
Data are presented as meanSD.
a The number of structures measured in each case are given within parenthesis
b Number of cases included in each control group for measurement of the GBM thickness
c Twenty separate measurements of the GBM in each biopsy
tion was monitored for 9 to 17 years. The two youngest
patients (II-6 and III-3) had stable or slightly increasing
serum creatinine. In two cases (II-2 and II-4), a moderate
increase of serum creatinine over several years was fol-
lowed by a serious progression toward ESRD and kidney
transplantation. The eldest family member (I-1) pre-
sented CRI much later at the age of 42 years, followed
by a moderate increase of the serum creatinine toward
CRF 10 years later.
Morphometric measurements
Area of the glomerular tuft and Bowman’s space. Cases
I-1, II-2, and II-6 showed increased area of the glomeru-
lar tuft and Bowman’s space compared with patients
diagnosed with benign nephrosclerosis and/or glomeru-
lonephritis (control group 2 and 3), as shown in Table
2 and Figure 3 A and B. In control group 1, the diabetic
nephropathy group, there was as expected increased glo-
merular area compared to control group 2 (P  0.0001).
The glomerular area in one mutation carrier (II-2) was
considerably larger than in group 1, whereas cases I-1
and II-6 had glomerular sizes comparable with diabetic
nephropathy. Subject III-3, on the other hand, demon-
strated normal-sized glomeruli.
Proximal and distal tubules. Hypertrophy of the proxi-
mal and distal tubules was found in mutation carriers I-1,
II-2 and II-6, compared with control groups (Fig. 3 C
and D). This hypertrophy was not found in case III-3,
although the distal tubules were widened in this mutation
carrier as well.
Glomerular basement membrane. The thickness of the
GBM in the mutation carriers was found to be near
normal (Table 2). As expected, control group 1 showed
increased GBM width. Case II-2 had slightly increased
GBM thickness (379  96 nm) compared with cases I-1
(363 100 nm) and II-6 (341 79 nm). Mutation carriers
did not differ from control groups 2 and 3 regarding
GBM thickness.
Morphologic examinations
Except for the enlarged nephrons, the renal biopsies
from all family members revealed nearly normal mor-
phology (Fig. 4). A few small areas of focal tubulointer-
stitial scarring with some scattered mononuclear in-
flammatory cells were found. In patients I-1 and II-6,
there was glomerular mesangial positivity for IgM and
C1q. Arteriolosclerosis was not shown in any of the renal
biopsies from the mutation carriers. No electron-dense
deposits or other significant findings were found by trans-
mission electron microscopy.
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Fig. 3. Morphometric measurements in kid-
ney biopsies from four patients with a hepato-
cyte nuclear factor-1 (HNF-1) mutation
and three control groups (control group 1, 13
adult subjects with diabetic nephropathy; con-
trol group 2, 11 adult subjects with glomerulo-
nephritis or benign nephrosclerosis; and con-
trol group 3, 12 children with minimal change
glomerulopathy or glomerulonephritis). The
area of the glomerular tuft (A ), Bowman’s
space (B ), diameter of the proximal tubules
(C ), and distal tubules (D ) were measured.
Dots indicate results obtained in individual
subjects, while transverse lines represent mean
values. For the mutation carriers, one dot rep-
resents the mean value of 2-5 (A and B), or
5-10 (C and D) measurements, whereas con-
trol values are based on 10 measurements for
each subject.
DISCUSSION
We have performed morphometric analyses of neph-
rons in renal biopsies from patients with an HNF-1muta-
tion, and demonstrated enlargement of glomeruli as well
as tubular structures. There was considerable intrafamilial
variation among the cases studied. Thus, a 13-year-old
girl (case II-2) showed a pattern of oligomeganephronia
[12, this report], with a reduced number of markedly
enlarged nephrons, whereas the nephrons of a 10-year-
old boy (case III-3) appeared as structurally near normal.
A similar phenotypic variation was found with respect
to the genital anomalies observed. Two females (cases
II-4 and II-6) had Mu¨llerian aplasia, with vaginal aplasia
and rudimentary uterus, whereas two other female muta-
tion carriers (cases I-1 and II-2) had had normal child
births. The phenotypic expression in this family is further
complicated by the fact that the presence of genital
anomalies was not necessarily associated with severe re-
nal disease. Nevertheless, we feel justified to conclude
that in this family there is a fundamental urogenital de-
velopmental defect related to the HNF-1 mutation.
Since one of our patients displayed a pattern of oligo-
meganephronia and this diagnosis was considered possi-
ble in two other mutation carriers, one may speculate
that the underlying renal defect in our patients relates
to a reduced number of nephrons. Unfortunately, due
to scarcity of biopsy material, this question could not be
addressed in detail.
The long-term clinical follow-up of this family demon-
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Fig. 4. Representative light microscopy of renal biopsies from case II-6 (panel 1), case II-2 (panel 2), a child from control group 3 with IgA
nephropathy (panel 3) and an adult patient with diabetic nephropathy (panel 4). The large arrows point to the glomeruli, and the arrow heads
point to the tubules. The black bar is 100 m. All microphotographs have the same degree of magnification (40 objective).
strates the early appearance and severity of renal disease,
compatible with a congenital disorder. In subject II-4,
there was evidence of a glomerular and tubular disorder
already in infancy, followed by increasing serum creati-
nine during childhood and adolescence, and renal trans-
plantation at age 21 years. Case II-2, with oligomega-
nephronia detected at age 13 years, had a renal transplant
15 years later.
Since diabetes mellitus is present in most cases with
HNF-1 mutations, and was observed in four of our
patients, we considered the possibility of a diabetic ne-
phropathy. Glomerular enlargement in addition to thick-
ening of the GBM are well-known structural changes in
diabetic nephropathy [16–18]. However, the following
arguments speak against such a possibility: (1) our pa-
tients showed microalbuminuria and increasing serum
creatinine prior to clinical diabetes; (2) renal ultrasonog-
raphy showed small or normal sized kidneys, contrary
to enlarged kidneys in early diabetic nephropathy; (3)
the GBM thickness was considered near normal in all
mutation carriers; (4) there was no evidence of arterio-
losclerosis in our patients; and (5) our patients presented
a relatively mild diabetes, with only slightly elevated
levels of glycosylated hemoglobin.
Proteinuria may be associated with tubulointerstitial
inflammation, renal scarring, and proximal tubular cell
proliferation [19–21]. The renal biopsies from our pa-
tients showed, in addition to tubular hypertrophy, only
small focal areas with scarring and scattered cellular in-
filtrates. However, the low-to-moderate urinary albumin
concentrations observed, probably played no significant
role in the renal pathology of the patients. Likewise,
hypertension may be excluded as a pathogenic factor,
since increased blood pressure was measured in one sub-
ject only (case I-1), at the age of 51 years.
Table 3 summarizes published histopathologic studies
of renal biopsies in HNF-1mutation carriers in addition
to the data presented here. Renal involvement (cysts,
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CRI, CRF, ESRD) was present in 47 patients, and absent
in four mutation carriers, whereas this was not com-
mented on three cases. Glomerulocystic kidney disease
or cystic dysplasia, which is reported in the literature,
was not found in our biopsy cases. A cystic kidney was
observed in case II-4 during a surgical intervention,
where no biopsy was obtained. The hypertrophy of the
nephrons observed in our patients has not been reported
by other investigators. In a total of 54 cases [1, 2, 4–7,
13–15, 22–25] the kidney disease was diagnosed prior to
diabetes in 29 patients, whereas the opposite was true
in 11 subjects. In 14 mutation carriers, this question was
not addressed. Thirty-seven patients had diabetes melli-
tus or IGT, whereas normoglycemia was reported in
14 mutation carriers. Totally, six mutation carriers (five
female and one male mutation carriers) had malforma-
tions of the genital tract.
CONCLUSION
Morphometric studies of kidney biopsies from a family
with HNF-1 mutation carriers demonstrated enlarged
glomeruli and tubular structures. The present and pre-
viously published reports underscore the wide interfamil-
ial and intrafamilial phenotypic variation of the renal
disease associated with HNF-1 mutations. The long-
term clinical follow-up illustrates the natural history of
the renal disease associated with HNF-1 mutation, and
together with the histopathologic examinations it strongly
suggest that the nephropathy starts prior to and indepen-
dently of diabetes.
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